ImmuCell Corporation

ICCC•United States

Healthcare United States In Vitro & In Vivo Diagnostic Substances

Need professional-grade analysis? Visit stockanalysis.com

$6.39

+5.27%

End of day

Market Cap

N/A

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	—	—	0.57	-0.11	0.58	-0.26	0.17
Calmar	—	—	1.30	-0.13	0.57	-0.13	0.33
Sharpe	—	—	0.39	-0.08	0.38	-0.17	0.11
Omega	—	—	1.11	1.03	1.13	1.01	1.07
Martin	—	—	3.19	-0.33	1.35	-0.21	0.82
Ulcer	—	—	5.76	12.58	16.98	44.05	21.93

ImmuCell Corporation (ICCC) Price Performance

ImmuCell Corporation (ICCC) trades on United States in USD. The company is classified in the Healthcare sector under the In Vitro & In Vivo Diagnostic Substances industry. The stock currently trades at $6.39, up 5.27% from the previous close.

Over the past year, ICCC has traded between a low of $4.56 and a high of $7.60. The stock has gained 33.7% over this period. It is currently 15.9% below its 52-week high.

Company Info

Sector: Healthcare
Industry: In Vitro & In Vivo Diagnostic Substances
Exchange: United States
Currency: USD
Country: United States

Financial Metrics

Revenue (TTM): $26.49M
EBITDA: N/A
Profit Margin: -8.14%
EPS (TTM): N/A
Book Value: 27.52

Technical Indicators

52 Week High: $7.60
52 Week Low: $4.52
50 Day MA: $6.39
200 Day MA: $6.23
Beta: N/A

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: N/A
Enterprise Value: N/A